Musculoskeletal Pain
📧 Sign up to get email alerts when something new happens for Musculoskeletal Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-06-11FDA Approved: DULOXETINE DELAYED-RELEASE — Original Application (Breckenridge Pharmaceutical, Inc.)
FDA approved Breckenridge Pharmaceutical's original generic duloxetine hydrochloride delayed-release capsules, a generic version of the anti…
-
FDA approval · 2014-06-09FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original ANDA for duloxetine hydrochloride, establishing a generic version of duloxetine.
-
FDA approval · 2014-04-29FDA Approved: ROBAXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Robaxin (methocarbamol) submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Returning to Work. Efficacy of "Tailored Physical Activity or" "Chronic Pain Self-management Program" in Sicklisted Citizens With Chronic Musculoskeletal Pain [Phase 1, Phase 2]
This clinical trial update reports the efficacy of tailored physical activity versus a chronic pain self-management program for sick-listed …
-
FDA approval · 2014-01-08FDA Approved: DULOXETINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for a duloxetine generic from Zydus Lifesciences Limited, enabling marketing for the same indications …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Blue Light Device for Pain Therapy [Phase 3]
Phase 3 trial of a blue light device for pain therapy in low back pain completed; results were posted in January 2014.
-
FDA approval · 2013-12-17FDA Approved: DULOXETINE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s original application for a generic duloxetine product. The approval makes low-cost generic duloxetine av…
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (MARKSANS PHARMA LIMITED)
FDA approves duloxetine hydrochloride generic by Marksans Pharma Limited under an Original ANDA (ANDA 090723).
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' original application for a generic duloxetine product (DULOXETINE). This approval allows the mar…
-
CLINICAL_TRIALS research · 2013-12-10Clinical Trial Update: Chronic Pain and Vitamin D [NA]
A clinical trial update for NCT02002000 examines vitamin D supplementation for chronic musculoskeletal pain; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Assessing the Feasibility of Integrating Ear Acupuncture Into the Aeromedical Evacuation System From RAB to AAFB
A completed clinical trial assessing the feasibility of integrating ear acupuncture into the aeromedical evacuation system for musculoskelet…
-
FDA approval · 2013-10-28FDA Approved: DICLOFENAC SODIUM — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal's Original Application for Diclofenac Sodium Tablets, a generic NSAID indicated for relief of pain and inflammation in s…
-
CLINICAL_TRIALS trial_result · 2013-10-09Clinical Trial Update: Automated Connective Tissue Torque Sensor
A clinical trial update indicates completion of the automated connective tissue torque sensor study sponsored by Stromatec, Inc., investigat…
-
FDA approval · 2013-07-30FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for cyclobenzaprine hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2013-06-07FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for cyclobenzaprine hydrochloride from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2013-04-30FDA Approved: CARISOPRODOL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for carisoprodol by Rising Pharma Holdings, Inc., indicating an approved modification to the existin…
-
FDA approval · 2013-04-18FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approves a supplemental application for Aleve GelCaps to expand labeling for naproxen sodium, broadening indications for pain relief.
-
FDA approval · 2013-04-11FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Solco Healthcare U.S., LLC)
FDA approves a supplemental application for Cyclobenzaprine Hydrochloride (Solco Healthcare U.S., LLC), authorizing the generic product to b…
-
FDA approval · 2013-04-11FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (KVK-TECH, Inc.)
FDA approved a supplemental application for cyclobenzaprine hydrochloride from KVK-Tech, Inc., allowing the generic product to proceed under…
-
FDA approval · 2013-04-11FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approved a supplemental application for cyclobenzaprine hydrochloride (generic) from Jubilant Cadista Pharmaceuticals, approving an …
-
FDA approval · 2013-04-11FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for cyclobenzaprine hydrochloride from Rising Pharma Holdings, Inc., confirming approval of a generi…
-
FDA approval · 2013-04-11FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for cyclobenzaprine hydrochloride from Teva Pharmaceuticals USA, Inc., updating the existing approva…
-
FDA approval · 2013-03-29FDA Approved: SALONPAS PAIN RELIEF — Supplemental Application (Hisamitsu Pharmaceutical Co., Inc.)
The FDA approved a supplemental application for SALONPAS PAIN RELIEF (menthol and methyl salicylate) from Hisamitsu Pharmaceutical Co., Inc.…
-
FDA approval · 2013-02-01FDA Approved: SOMA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Soma (carisoprodol) submitted by Viatris Specialty LLC.
-
FDA approval · 2013-01-31FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith's generic cyclobenzaprine hydrochloride for use as a muscle relaxant in acute musculoskeletal conditions under…